Maritim Charity, McClarty Leigh, Leung Stella, Bruce Sharon, Restall Gayle, Migliardi Paula, Becker Marissa
Institute for Global Public Health, University of Manitoba, Winnipeg, Manitoba, Canada.
Department of Occupational Therapy, University of Manitoba, Winnipeg, Manitoba, Canada.
J Assoc Med Microbiol Infect Dis Can. 2021 Jul 20;6(2):119-128. doi: 10.3138/jammi-2020-0042. eCollection 2021 Jun.
Despite the overrepresentation of immigrants and refugees (newcomers) in the HIV epidemic in Canada, research on their HIV treatment outcomes is limited. This study addressed this knowledge gap by describing treatment outcomes of newcomers in comparison with Canadian-born persons living with HIV in Manitoba.
Clinical data from 1986 to 2017 were obtained from a cohort of people living with HIV and receiving care from the Manitoba HIV Program. Retrospective cohort analysis of secondary data was completed using univariate and multivariate statistics to compare differences in socio-demographic and clinical characteristics and treatment outcomes among newcomers, Canadian-born Indigenous persons, and Canadian-born non-Indigenous persons on entry into HIV care.
By end of 2017, 86 newcomers, 259 Canadian-born Indigenous persons, and 356 Canadian-born non-Indigenous persons were enrolled in the cohort. Newcomers were more likely than Canadian-born Indigenous and non- Indigenous cohort participants to be younger and female and have self-reported HIV risk exposure as heterosexual contact. Average CD4 counts at entry into care did not differ significantly between groups. A higher proportion of newcomers was also diagnosed with tuberculosis within 6 months of entry into care (21%), compared with 6% and 0.6% of Canadian-born Indigenous non-Indigenous persons, respectively. Newcomers and Canadian-born non-Indigenous persons had achieved viral load suppression (< 200 copies/mL) at a similar proportion (93%), compared with 82% of Canadian-born Indigenous participants ( < 0.05).
The distinct demographic and clinical characteristics of newcomers living with HIV requires a focused approach to facilitate earlier diagnosis, engagement, and support in care.
尽管移民和难民(新移民)在加拿大的艾滋病流行中占比过高,但关于他们的艾滋病治疗结果的研究却很有限。本研究通过描述新移民与曼尼托巴省感染艾滋病毒的加拿大本土居民的治疗结果,填补了这一知识空白。
从一组感染艾滋病毒并接受曼尼托巴省艾滋病项目护理的人群中获取了1986年至2017年的临床数据。使用单变量和多变量统计方法对二次数据进行回顾性队列分析,以比较新移民、加拿大本土原住民和加拿大本土非原住民在开始接受艾滋病护理时的社会人口统计学和临床特征以及治疗结果的差异。
到2017年底,该队列纳入了86名新移民、259名加拿大本土原住民和356名加拿大本土非原住民。新移民比加拿大本土原住民和非原住民队列参与者更年轻,女性比例更高,并且自我报告的艾滋病毒风险暴露为异性接触。各群体开始接受护理时的平均CD4细胞计数没有显著差异。与加拿大本土原住民和非原住民分别为6%和0.6%相比,更高比例的新移民在开始接受护理后的6个月内被诊断出患有结核病(21%)。新移民和加拿大本土非原住民实现病毒载量抑制(<200拷贝/毫升)的比例相似(93%),而加拿大本土原住民参与者的这一比例为82%(<0.05)。
感染艾滋病毒的新移民独特的人口统计学和临床特征需要一种有针对性的方法,以促进早期诊断、参与护理并提供支持。